• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人哮喘中患者报告的呼吸道症状对病理生理学的揭示:一项横断面研究

When patient-reported respiratory symptoms shed light on pathophysiology in adult asthma: a cross-sectional study.

作者信息

Louis Gilles, Pétré Benoit, Sousa-Pinto Bernardo, Bousquet Jean, Van Ganse Éric, Schleich Florence, Louis Renaud

机构信息

Department of Public Health, University of Liège, Liège, Belgium.

Department of Pneumology, GIGAI3, University of Liège, Liège, Belgium.

出版信息

Sci Rep. 2024 Dec 2;14(1):29997. doi: 10.1038/s41598-024-81745-9.

DOI:10.1038/s41598-024-81745-9
PMID:39623071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11612149/
Abstract

While studies have demonstrated the impact of asthma symptoms on quality of life, very few studies have investigated the relationship between detailed asthma symptoms, as reported by the patient, and lung function and inflammation. A cross-sectional study was conducted on treated (ICS/LABA) adult (> 18 years) asthma patients recruited from the Liege University Hospital Asthma Clinic (Belgium) between 2018 and 2023 (n = 505). The intensity of asthma symptoms (dyspnea, wheezing, chest tightness, cough, and airway secretion) was measured using five-point Likert scales (5 expressing the greatest intensity). Multiple linear regression models including all independent variables were carried out to evaluate whether lung function and inflammatory parameters were independently associated with distinct symptoms. Cough associated with female gender (p < 0.05), smoking (p < 0.01), low FeNO (p < 0.05) and FEV1% pred. (p < 0.05), and high blood and sputum eosinophils (p < 0.05 for both). Airway secretion associated with smoking (p < 0.05). Chest tightness associated with young age (p < 0.001), female gender (p < 0.05) and low FEV1% pred. (p < 0.01). Dyspnea associated with female gender (p < 0.001), high BMI (p < 0.05), low FEV1% pred. (p < 0.0001) and high FEV1/FVC % (p < 0.01). Wheezing associated with young age (p < 0.01), high BMI (p < 0.05), smoking (p < 0.01), low FEV1% pred. (p < 0.0001) and high FEV1/FVC % (p < 0.05). Different respiratory symptoms are associated with distinct demographic, functional and inflammatory features paving the way for personalized therapeutic interventions.

摘要

虽然已有研究证明哮喘症状对生活质量的影响,但很少有研究调查患者报告的详细哮喘症状与肺功能及炎症之间的关系。对2018年至2023年间从列日大学医院哮喘诊所(比利时)招募的接受治疗(吸入糖皮质激素/长效β2受体激动剂)的成年(>18岁)哮喘患者进行了一项横断面研究(n = 505)。使用五点李克特量表测量哮喘症状(呼吸困难、喘息、胸闷、咳嗽和气道分泌物)的强度(5表示强度最大)。进行了包括所有自变量的多元线性回归模型,以评估肺功能和炎症参数是否与不同症状独立相关。咳嗽与女性性别(p < 0.05)、吸烟(p < 0.01)、低呼出一氧化氮(FeNO)(p < 0.05)和预计第一秒用力呼气容积(FEV1%)(p < 0.05)以及高血液和痰液嗜酸性粒细胞(两者均p < 0.05)相关。气道分泌物与吸烟(p < 0.05)相关。胸闷与年轻(p < 0.001)、女性性别(p < 0.05)和低预计FEV1%(p < 0.01)相关。呼吸困难与女性性别(p < 0.001)、高体重指数(BMI)(p < 0.05)、低预计FEV1%(p < 0.0001)和高FEV1/用力肺活量(FVC)%(p < 0.01)相关。喘息与年轻(p < 0.01)、高BMI(p < 0.05)、吸烟(p < 0.01)、低预计FEV1%(p < 0.0001)和高FEV1/FVC %(p < 0.05)相关。不同的呼吸道症状与不同的人口统计学、功能和炎症特征相关,为个性化治疗干预铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ba/11612149/00c12791515b/41598_2024_81745_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ba/11612149/f973b5e939a3/41598_2024_81745_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ba/11612149/bc77b5c06b84/41598_2024_81745_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ba/11612149/33dbdf9d44ca/41598_2024_81745_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ba/11612149/00c12791515b/41598_2024_81745_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ba/11612149/f973b5e939a3/41598_2024_81745_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ba/11612149/bc77b5c06b84/41598_2024_81745_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ba/11612149/33dbdf9d44ca/41598_2024_81745_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ba/11612149/00c12791515b/41598_2024_81745_Fig4_HTML.jpg

相似文献

1
When patient-reported respiratory symptoms shed light on pathophysiology in adult asthma: a cross-sectional study.成人哮喘中患者报告的呼吸道症状对病理生理学的揭示:一项横断面研究
Sci Rep. 2024 Dec 2;14(1):29997. doi: 10.1038/s41598-024-81745-9.
2
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
3
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
4
[Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].[采用层次聚类分析和两步聚类分析对症状性慢性气道疾病临床表型的研究]
Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):679-83. doi: 10.3760/cma.j.issn.0578-1426.2016.09.005.
5
Relationship between airway obstruction and respiratory symptoms in adult asthmatics.成年哮喘患者气道阻塞与呼吸道症状之间的关系
Chest. 1998 Feb;113(2):272-7. doi: 10.1378/chest.113.2.272.
6
[Correlation between pulmonary quantitative CT measurement indicators and respiratory symptoms in patients with chronic obstructive pulmonary disease in stable stage].[稳定期慢性阻塞性肺疾病患者肺部CT定量测量指标与呼吸症状的相关性]
Zhonghua Yi Xue Za Zhi. 2023 Oct 17;103(38):3017-3025. doi: 10.3760/cma.j.cn112137-20230418-00627.
7
Occupational exposures and respiratory symptoms and lung function among hairdressers in Iran: a cross-sectional study.伊朗理发师的职业暴露与呼吸道症状和肺功能:一项横断面研究。
Int Arch Occup Environ Health. 2021 Jul;94(5):877-887. doi: 10.1007/s00420-020-01645-z. Epub 2021 Jan 18.
8
Assessment of diagnostic accuracy of lung function indices and FeNO for a positive methacholine challenge.评估肺功能指标和 FeNO 对乙酰甲胆碱激发试验阳性的诊断准确性。
Biochem Pharmacol. 2020 Sep;179:113981. doi: 10.1016/j.bcp.2020.113981. Epub 2020 Apr 17.
9
Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.真实环境中哮喘和/或慢性阻塞性肺疾病患者的症状与肺功能的关系:NOVEL 观察性纵向研究。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241254212. doi: 10.1177/17534666241254212.
10
How respiratory symptoms impact asthma-related quality of life in mild asthmatics.轻度哮喘患者的呼吸道症状如何影响哮喘相关生活质量。
Respir Med. 2023 Feb;207:107098. doi: 10.1016/j.rmed.2022.107098. Epub 2022 Dec 28.

引用本文的文献

1
Association and risk factors analysis of FeNO and CRP in bronchial asthma combined with obstructive sleep apnea.支气管哮喘合并阻塞性睡眠呼吸暂停患者中呼出气一氧化氮(FeNO)与C反应蛋白(CRP)的相关性及危险因素分析
Front Med (Lausanne). 2025 Jun 30;12:1546389. doi: 10.3389/fmed.2025.1546389. eCollection 2025.
2
Comparison of usability and user-friendliness of three FeNO analyzers in a general population cohort of the LEAD study.在LEAD研究的普通人群队列中对三种呼出气一氧化氮(FeNO)分析仪的易用性和用户友好性进行比较。
Sci Rep. 2025 Mar 10;15(1):8255. doi: 10.1038/s41598-025-92664-8.

本文引用的文献

1
Management Reality of Female Patients with COPD: A Multicenter Cross-Sectional CAP Study in Japan.COPD 女性患者管理的现实状况:日本多中心 CAP 研究的横断面分析。
Int J Chron Obstruct Pulmon Dis. 2024 May 23;19:1123-1130. doi: 10.2147/COPD.S455397. eCollection 2024.
2
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.贝那鲁肽治疗重度嗜酸性粒细胞性哮喘患者的每日维持吸入性皮质类固醇的降低(SHAMAL):一项随机、多中心、开放性、4 期研究。
Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7.
3
Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia exhaled nitric oxide fraction - PROMISE.
倍利珠单抗在重度嗜酸性粒细胞性哮喘真实世界中的应用:已证实的有效性及对痰液嗜酸性粒细胞、呼出一氧化氮分数的对比影响——PROMISE研究
ERJ Open Res. 2023 Nov 27;9(6). doi: 10.1183/23120541.00383-2023. eCollection 2023 Nov.
4
Back to the roots of medicine: It's severe asthma patient-reported symptoms that matter!回归医学根源:严重哮喘患者报告的症状才是关键!
Pulmonology. 2023 Dec;29 Suppl 4:S92-S95. doi: 10.1016/j.pulmoe.2023.10.005. Epub 2023 Nov 11.
5
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study.哮喘患者吸入性糖皮质激素和长效β2受体激动剂的依从性:一项MASK-air研究。
Pulmonology. 2025 Dec 31;31(1):2416869. doi: 10.1016/j.pulmoe.2023.07.004. Epub 2024 Oct 25.
6
Strength of association between comorbidities and asthma: a meta-analysis.共病与哮喘之间关联强度的荟萃分析。
Eur Respir Rev. 2023 Mar 8;32(167). doi: 10.1183/16000617.0202-2022. Print 2023 Mar 31.
7
Predictors of change in asthma-related quality of life: a longitudinal real-life study in adult asthmatics.哮喘相关生活质量变化的预测因素:成人哮喘患者的纵向真实生活研究。
Qual Life Res. 2023 May;32(5):1507-1520. doi: 10.1007/s11136-022-03339-0. Epub 2023 Jan 3.
8
How respiratory symptoms impact asthma-related quality of life in mild asthmatics.轻度哮喘患者的呼吸道症状如何影响哮喘相关生活质量。
Respir Med. 2023 Feb;207:107098. doi: 10.1016/j.rmed.2022.107098. Epub 2022 Dec 28.
9
The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study.小气道功能障碍在哮喘控制和恶化中的作用:一项使用 ATLANTIS 研究数据的纵向观察性分析。
Lancet Respir Med. 2022 Jul;10(7):661-668. doi: 10.1016/S2213-2600(21)00536-1. Epub 2022 Mar 2.
10
European Respiratory Society guidelines for the diagnosis of asthma in adults.欧洲呼吸学会成人哮喘诊断指南。
Eur Respir J. 2022 Sep 7;60(3). doi: 10.1183/13993003.01585-2021. Print 2022 Sep.